Mr. Nosta was re-elected to the Myos Rens Board in December 2016. He is the founder of NOSTALAB—a digital health think-tank and marketing consulting company. A leading voice in the convergence of technology and health, Mr. Nosta helps define, dissect and deliberate global trends in digital health. He is consistently ranked among the top names in almost every digital health list and has sustained that position for several years. Beyond simply an influencer, he is also defined as “most admired” to “top disruptor” in digital health, life sciences and the pharmaceutical industry. As a member of the Google Health Advisory Board, Mr. Nosta has penned HEALTH CRITICAL for Forbes--a top global blog on health and technology. For over 20 years, he was part of leadership of leading healthcare communication companies for Omnicom and WPP. Prior to founding NOSTALAB, Mr. Nosta was employed by Ogilvy CommonHealth (WPP) for 10 years from 2003 to 2013, where he held a series of positions including Chief Creative Officer, Chief Strategic Officer, and unit President. Prior to this, he held various senior level positions at LLNS (Omnicom) from 1990 to 1997. Earlier in his career, Mr. Nosta was a research associate at Harvard Medical School and co-authored several papers with global thought-leaders in the field of cardiovascular physiology. He received a Bachelor of Arts degree from Boston University in 1981. We believe Mr. Nosta’s extensive professional background, including his global marketing and medical experience qualifies him to serve on our Board of Directors.